关键词: CoQ-10 cardiovascular disorders coenzyme Q10 heart failure ubiquinol

Mesh : Humans Heart Failure / drug therapy physiopathology Ubiquinone / analogs & derivatives therapeutic use pharmacology Stroke Volume / physiology Exercise Tolerance / physiology drug effects Ventricular Function, Left / physiology drug effects Treatment Outcome

来  源:   DOI:10.1080/14796678.2024.2352308   PDF(Pubmed)

Abstract:
Aim: We aim to analyze past literature to evaluate the efficacy of coenzyme Q10 (CoQ-10) in the population with heart failure (HF). Methods: A systematic literature search was conducted through MEDLINE (via PubMed) and Cochrane Library. The outcomes analyzed were a reduction in HF-related mortality, an improvement in exercise capacity, and the left ventricular ejection fraction (LVEF). Results: Among 16 studies, CoQ-10 significantly reduced HF-related mortality by 40% and improved exercise capacity in patients with HF, but demonstrated no significant difference in LVEF however, the potential of its efficacy on LVEF could not be ruled out. Conclusion: CoQ-10 significantly enhances exercise capacity and reduces HF-related mortality; however, its impact on patients with reduced LVEF requires further investigation.
[Box: see text].
摘要:
目的:我们旨在分析过去的文献,以评估辅酶Q10(CoQ-10)在心力衰竭(HF)人群中的疗效。方法:通过MEDLINE(通过PubMed)和Cochrane图书馆进行系统的文献检索。分析的结果是HF相关死亡率的降低,锻炼能力的提高,左心室射血分数(LVEF)。结果:在16项研究中,CoQ-10可显著降低HF相关死亡率40%,改善HF患者的运动能力,但显示LVEF没有显着差异,不能排除其对LVEF的潜在疗效.结论:CoQ-10能显著增强运动能力,降低HF相关死亡率;然而,其对LVEF降低患者的影响需要进一步研究.
[方框:见正文]。
公众号